Dermira Revenue and Competitors



Total Funding



Estimated Revenue & Valuation

  • Dermira's estimated annual revenue is currently $42.3M per year.(i)
  • Dermira received $250.0M in venture funding in May 2017.
  • Dermira's estimated revenue per employee is $1,693,560
  • Dermira's total funding is $599.3M.

Employee Data

  • Dermira has 25 Employees.(i)
  • Dermira grew their employee count by -11% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

Dermira is a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions. We are committed to understanding and addressing the needs of both patients and physicians, and using our experience and insight to identify and develop leading-edge medical dermatology clinical programs. Our goal is to help transform the way skin conditions are treated by serving as the bridge between unmet patient needs and the significant scientific advances being made in understanding skin biology. Learn more about who we are and what we do by visiting Here are our community guidelines:

keywords:Biotechnology,Enterprise Software,Health It,Healthcare,Pharmaceuticals


Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Dermira News

2022-04-20 - Acne Vulgaris Treatment Market Size, Outlook And Forecast ...

Common Pharma Inc, Cutanea Life Sciences Inc, Dermira Inc, ELORAC Inc, Ensol Biosciences Inc, Foamix Pharmaceuticals Ltd, Galderma SA, GlaxoSmithKline Plc,...

2022-04-17 - Tom Wiggans to receive KU Pharmacy Distinguished Service ...

Wiggans then co-founded Dermira Inc., a biotech firm in Menlo Park, California. As CEO and director, Wiggans helped make Dermira an...

2022-03-22 - Cala Health Expands Leadership Team to Fuel Growth and ...

Prior to UCB, Jeron served as Senior Vice President of Commercial Operations at Dermira, Inc., a fully integrated specialty pharmaceutical...

2020-01-13 - Eli Lilly acquires skin disease-focused Dermira in $1.1B deal

Dermira has one approved product, Qbrexza (glycopyrronium), a medicated cloth used to treat primary axillary hyperhidrosis, or excessive underarm sweating. The lead product candidate in its pipeline is lebrikizumab, a monoclonal antibody in Phase III development designed to treat moderate to sev ...

2019-09-08 - Aperio Group LLC Raises Stock Holdings in Dermira Inc (NASDAQ:DERM)

Aperio Group LLC boosted its holdings in shares of Dermira Inc (NASDAQ:DERM) by 24.4% during the second quarter, according to its most ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding

Dermira Funding

DateAmountRoundLead InvestorsReference
2013-06-12$35.0MBMaruho Co LtdArticle
2015-08-06$UndisclosedUndisclosedLeerink Partners LLC,Article
2017-03-09$193.8MUndisclosedLeerink Partners LLC,Article

Dermira Executives

Luis PenaChief Development Officer/Founder
Christopher horanChief technical operation officer
Thomas WiggansCEO
Chris GriffithFounder/VP Corporate Development/Strategy
Lori Cianoseior vp Human Resources
Janice DrewSVP, Portfolio Planning and Management
Ray BassiVice President of Sales
Tracy VanDenBergVice President, Head of Human Resources
Carly LoebVice President, Commercial Insights & Operations
Jeron EvansVice President, Commercial Operations
Diane HagertySenior Vice President - Quality, Compliance & Operational Excellence
Delphine ImbertSVP, Pharmaceutical Sciences